Rekvina Labs

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE092O01028
  • NSEID:
  • BSEID: 526075
INR
7.43
0.35 (4.94%)
BSENSE

Jan 14

BSE+NSE Vol: 250

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Rekvina Labs Ltd stock-summary
stock-summary
Rekvina Labs Ltd
Micro Cap
Pharmaceuticals & Drugs
Rekvina Laboratories Ltd is committed to provide quality medication at affordable prices to the patients with a view to help bring down the healthcare costs.
Company Coordinates stock-summary
Company Details
328 Paradise Complex, Sayajigunj Vadodara Gujarat : 390005
stock-summary
Tel: 91-265-2362966
stock-summary
rekvina@gmail.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 3.01 Cr
Number of Shares
60.28 Cr
Face Value
INR 5.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
30-Apr-2014
60.28
3.01
3014000
5
Stock Split
30-Apr-2014
60.28
3.01
3014000
5
Stock Split
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Surbhit Mukesh Shah (15.22%)

Highest Public shareholder

Viralkumar Tribhovandas Patel (4.388%)

Individual Investors Holdings

51.98%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Amit Shah
Director
0
Mukesh Shah
Director
0
Vibha Mukesh Shah
Additional Director
0
Mahendra Shantilal Dalal
Additional Director
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
 
Icon
No Data Available
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Sep 2019)
Net Profit:
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 4 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

-28.40%

stock-summary
Price to Book

4.27